Kezhen Lv

764 total citations
15 papers, 654 citations indexed

About

Kezhen Lv is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kezhen Lv has authored 15 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Kezhen Lv's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (5 papers) and RNA Research and Splicing (3 papers). Kezhen Lv is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (5 papers) and RNA Research and Splicing (3 papers). Kezhen Lv collaborates with scholars based in China. Kezhen Lv's co-authors include Xiaojiao Liu, Peifen Fu, Minya Yao, Haiyan Wei, Yaomin Chen, Yu Liu, Feiya Du, Yu Liu, Peifen Fu and Wenxian Hu and has published in prestigious journals such as PLoS ONE, Experimental Cell Research and Oncotarget.

In The Last Decade

Kezhen Lv

15 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kezhen Lv China	13	396	285	169	76	56	15	654
Sifeng Tao China	11	371 0.9×	210 0.7×	92 0.5×	80 1.1×	46 0.8×	16	645
Eleftheria Ignatiadou Greece	5	212 0.5×	172 0.6×	172 1.0×	68 0.9×	117 2.1×	9	553
Baixia Yang China	13	269 0.7×	196 0.7×	117 0.7×	81 1.1×	71 1.3×	22	502
Jianning Yao China	12	289 0.7×	197 0.7×	72 0.4×	57 0.8×	58 1.0×	32	468
Quan Jiang China	15	213 0.5×	95 0.3×	169 1.0×	115 1.5×	43 0.8×	30	534
Xinlan Lu China	17	487 1.2×	368 1.3×	88 0.5×	117 1.5×	141 2.5×	40	790
Jichao Wei China	12	300 0.8×	179 0.6×	121 0.7×	65 0.9×	75 1.3×	22	557
Xianghong Yang China	16	353 0.9×	153 0.5×	290 1.7×	102 1.3×	117 2.1×	35	719
Ye Leng China	11	559 1.4×	224 0.8×	156 0.9×	50 0.7×	80 1.4×	22	774
Pihong Li China	12	243 0.6×	107 0.4×	86 0.5×	61 0.8×	56 1.0×	23	456

Countries citing papers authored by Kezhen Lv

Since Specialization

Citations

This map shows the geographic impact of Kezhen Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kezhen Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kezhen Lv more than expected).

Fields of papers citing papers by Kezhen Lv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kezhen Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kezhen Lv. The network helps show where Kezhen Lv may publish in the future.

Co-authorship network of co-authors of Kezhen Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Kezhen Lv. A scholar is included among the top collaborators of Kezhen Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kezhen Lv. Kezhen Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hu, Wenxian, Kezhen Lv, Rongyue Teng, et al.. (2021). Pegylated Liposomal Doxorubicin Versus Epirubicin as Adjuvant Therapy for Stage I–III Breast Cancer. Frontiers in Genetics. 12. 746114–746114. 8 indexed citations

Du, Chengyong, Xiaochen Zhang, Minya Yao, et al.. (2018). Bcl‑2 promotes metastasis through the epithelial‑to‑mesenchymal transition in the BCap37 medullary breast cancer cell line. Oncology Letters. 15(6). 8991–8898. 23 indexed citations

Chen, Yongxia, et al.. (2018). The Expression Profiles of MicroRNA Let-7a in Peripheral Blood Mononuclear Cells from Patients of Gastric Cancer with Neoadjuvant Chemotherapy. Clinical Laboratory. 64(05/2018). 835–839. 1 indexed citations

Chen, Yaomin, Yu Liu, Haiyan Wei, Kezhen Lv, & Peifen Fu. (2016). Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells. Tumor Biology. 37(8). 10861–10870. 77 indexed citations

Chen, Yaomin, Yu Liu, Haiyan Wei, Kezhen Lv, & Peifen Fu. (2016). Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells. Oncotarget. 7(37). 59604–59617. 47 indexed citations

Hu, Wenxian, Yunlu Jia, Xiangsheng Xiao, et al.. (2016). KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth. Oncotarget. 7(33). 52870–52887. 30 indexed citations

Fu, Peifen, Minya Yao, Yu Liu, et al.. (2014). Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer. OncoTargets and Therapy. 7. 1743–1743. 75 indexed citations

Fu, Peifen, Feiya Du, Minya Yao, Kezhen Lv, & Yu Liu. (2014). MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells. Experimental and Therapeutic Medicine. 8(6). 1879–1883. 29 indexed citations

Li, Yu, Feiya Du, Wei Chen, et al.. (2014). EIF5A2 is a novel chemoresistance gene in breast cancer. Breast Cancer. 22(6). 602–607. 27 indexed citations

10.

Fu, Peifen, Feiya Du, Wei Chen, et al.. (2014). Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines. Oncology Reports. 31(6). 2561–2568. 41 indexed citations

11.

Wang, Linbo, Chao Yuan, Kezhen Lv, et al.. (2013). Lin28 Mediates Radiation Resistance of Breast Cancer Cells via Regulation of Caspase, H2A.X and Let-7 Signaling. PLoS ONE. 8(6). e67373–e67373. 38 indexed citations

12.

Liu, Yu, Feiya Du, Wei Chen, et al.. (2013). Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin. Experimental Cell Research. 319(20). 3140–3149. 33 indexed citations

13.

Liu, Xiaojiao & Kezhen Lv. (2012). Cruciferous vegetables intake is inversely associated with risk of breast cancer: A meta-analysis. The Breast. 22(3). 309–313. 121 indexed citations

14.

Lv, Kezhen, Liqun Liu, Linbo Wang, et al.. (2012). Lin28 Mediates Paclitaxel Resistance by Modulating p21, Rb and Let-7a miRNA in Breast Cancer Cells. PLoS ONE. 7(7). e40008–e40008. 63 indexed citations

15.

Yang, Weili, Jiren Yu, Yijun Wu, et al.. (2009). Duodenal gastrointestinal stromal tumor: Clinical, pathologic, immunohistochemical characteristics, and surgical prognosis. Journal of Surgical Oncology. 100(7). 606–610. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact